Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Market Snapshot
6.1 Global
6.2 Regional
7 Opportunities and Challenges in the Market
8 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
8.1 Key Industry Highlights
8.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market (2019-2025)
8.3 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast (2026-2035)
8.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market by Indication
8.4.1 Lung Cancer
8.4.1.1 Historical Trend (2019-2025)
8.4.1.2 Forecast Trend (2026-2035)
8.4.2 Colorectal Cancer
8.4.2.1 Historical Trend (2019-2025)
8.4.2.2 Forecast Trend (2026-2035)
8.4.3 Breast Cancer
8.4.3.1 Historical Trend (2019-2025)
8.4.3.2 Forecast Trend (2026-2035)
8.4.4 Others
8.5 Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market by Region
8.5.1 North America
8.5.1.1 Historical Trend (2019-2025)
8.5.1.2 Forecast Trend (2026-2035)
8.5.2 Europe
8.5.2.1 Historical Trend (2019-2025)
8.5.2.2 Forecast Trend (2026-2035)
8.5.3 Asia Pacific
8.5.3.1 Historical Trend (2019-2025)
8.5.3.2 Forecast Trend (2026-2035)
8.5.4 Latin America
8.5.4.1 Historical Trend (2019-2025)
8.5.4.2 Forecast Trend (2026-2035)
8.5.5 Middle East and Africa
8.5.5.1 Historical Trend (2019-2025)
8.5.5.2 Forecast Trend (2026-2035)
9 North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
9.1 United States of America
9.1.1 Historical Trend (2019-2025)
9.1.2 Forecast Trend (2026-2035)
9.2 Canada
9.2.1 Historical Trend (2019-2025)
9.2.2 Forecast Trend (2026-2035)
10 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
10.1 United Kingdom
10.1.1 Historical Trend (2019-2025)
10.1.2 Forecast Trend (2026-2035)
10.2 Germany
10.2.1 Historical Trend (2019-2025)
10.2.2 Forecast Trend (2026-2035)
10.3 France
10.3.1 Historical Trend (2019-2025)
10.3.2 Forecast Trend (2026-2035)
10.4 Italy
10.4.1 Historical Trend (2019-2025)
10.4.2 Forecast Trend (2026-2035)
10.5 Others
11 Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
11.1 China
11.1.1 Historical Trend (2019-2025)
11.1.2 Forecast Trend (2026-2035)
11.2 Japan
11.2.1 Historical Trend (2019-2025)
11.2.2 Forecast Trend (2026-2035)
11.3 India
11.3.1 Historical Trend (2019-2025)
11.3.2 Forecast Trend (2026-2035)
11.4 ASEAN
11.4.1 Historical Trend (2019-2025)
11.4.2 Forecast Trend (2026-2035)
11.5 Australia
11.5.1 Historical Trend (2019-2025)
11.5.2 Forecast Trend (2026-2035)
11.6 Others
12 Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
12.1 Brazil
12.1.1 Historical Trend (2019-2025)
12.1.2 Forecast Trend (2026-2035)
12.2 Argentina
12.2.1 Historical Trend (2019-2025)
12.2.2 Forecast Trend (2026-2035)
12.3 Mexico
12.3.1 Historical Trend (2019-2025)
12.3.2 Forecast Trend (2026-2035)
12.4 Others
13 Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Analysis
13.1 Saudi Arabia
13.1.1 Historical Trend (2019-2025)
13.1.2 Forecast Trend (2026-2035)
13.2 United Arab Emirates
13.2.1 Historical Trend (2019-2025)
13.2.2 Forecast Trend (2026-2035)
13.3 Nigeria
13.3.1 Historical Trend (2019-2025)
13.3.2 Forecast Trend (2026-2035)
13.4 South Africa
13.4.1 Historical Trend (2019-2025)
13.4.2 Forecast Trend (2026-2035)
13.5 Others
14 Market Dynamics
14.1 SWOT Analysis
14.1.1 Strengths
14.1.2 Weaknesses
14.1.3 Opportunities
14.1.4 Threats
14.2 Porter’s Five Forces Analysis
14.2.1 Supplier’s Power
14.2.2 Buyer’s Power
14.2.3 Threat of New Entrants
14.2.4 Degree of Rivalry
14.2.5 Threat of Substitutes
14.3 Key Indicators for Demand
14.4 Key Indicators for Price
15 Competitive Landscape
15.1 Market Structure
15.2 Company Profiles
15.2.1 Amgen Inc.
15.2.1.1 Company Overview
15.2.1.2 Product Portfolio
15.2.1.3 Demographic Reach and Achievements
15.2.1.4 Certifications
15.2.2 Novartis AG
15.2.2.1 Company Overview
15.2.2.2 Product Portfolio
15.2.2.3 Demographic Reach and Achievements
15.2.2.4 Certifications
15.2.3 AstraZeneca PLC
15.2.3.1 Company Overview
15.2.3.2 Product Portfolio
15.2.3.3 Demographic Reach and Achievements
15.2.3.4 Certifications
15.2.4 Eli Lilly and Company
15.2.4.1 Company Overview
15.2.4.2 Product Portfolio
15.2.4.3 Demographic Reach and Achievements
15.2.4.4 Certifications
15.2.5 F. Hoffmann-La Roche Ltd.
15.2.5.1 Company Overview
15.2.5.2 Product Portfolio
15.2.5.3 Demographic Reach and Achievements
15.2.5.4 Certifications
15.2.6 Johnson & Johnson Services, Inc.
15.2.6.1 Company Overview
15.2.6.2 Product Portfolio
15.2.6.3 Demographic Reach and Achievements
15.2.6.4 Certifications
15.2.7 Others
16 Key Trends and Developments in the Market
List of Key Figures and Tables
1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market: Key Industry Highlights, 2019 and 2035
2. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Indication (USD Million), 2019-2025
3. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Indication (USD Million), 2026-2035
4. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Region (USD Million), 2019-2025
5. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Region (USD Million), 2026-2035
6. North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Country (USD Million), 2019-2025
7. North America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Country (USD Million), 2026-2035
8. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Country (USD Million), 2019-2025
9. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Country (USD Million), 2026-2035
10. Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Country (USD Million), 2019-2025
11. Asia Pacific Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Country (USD Million), 2026-2035
12. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Country (USD Million), 2019-2025
13. Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Country (USD Million), 2026-2035
14. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Historical Market: Breakup by Country (USD Million), 2019-2025
15. Middle East and Africa Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Forecast: Breakup by Country (USD Million), 2026-2035
16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitors Market Structure